Perrigo Current Ratio 2010-2025 | PRGO

Perrigo current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Perrigo Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $2.53B $1.07B 2.36
2024-12-31 $2.48B $1.04B 2.38
2024-09-30 $3.71B $1.45B 2.56
2024-06-30 $2.96B $1.49B 1.99
2024-03-31 $2.81B $1.56B 1.81
2023-12-31 $2.83B $1.59B 1.79
2023-09-30 $2.77B $1.01B 2.74
2023-06-30 $2.77B $1.06B 2.62
2023-03-31 $2.74B $1.09B 2.52
2022-12-31 $2.72B $1.11B 2.44
2022-09-30 $2.58B $1.02B 2.55
2022-06-30 $2.65B $1.02B 2.61
2022-03-31 $3.94B $0.98B 4.01
2021-12-31 $3.86B $1.59B 2.43
2021-09-30 $4.23B $2.00B 2.11
2021-06-30 $4.42B $1.99B 2.23
2021-03-31 $4.49B $1.45B 3.10
2020-12-31 $3.13B $1.38B 2.27
2020-09-30 $3.40B $1.34B 2.54
2020-06-30 $3.80B $1.86B 2.05
2020-03-31 $3.05B $1.64B 1.86
2019-12-31 $2.73B $1.34B 2.04
2019-09-30 $2.74B $1.33B 2.07
2019-06-30 $3.44B $1.79B 1.92
2019-03-31 $3.01B $1.83B 1.64
2018-12-31 $2.90B $1.54B 1.89
2018-09-30 $2.77B $1.49B 1.85
2018-06-30 $2.78B $1.54B 1.81
2018-03-31 $2.90B $1.39B 2.08
2017-12-31 $2.82B $1.44B 1.96
2017-09-30 $2.97B $1.73B 1.72
2017-06-30 $2.82B $1.63B 1.73
2017-03-31 $5.11B $2.49B 2.06
2016-12-31 $2.81B $1.84B 1.53
2016-09-30 $2.62B $1.51B 1.73
2016-06-30 $3.03B $2.06B 1.47
2016-03-31 $3.02B $2.22B 1.36
2015-12-31 $2.79B $2.55B 1.09
2015-09-30 $2.88B $1.66B 1.73
2015-06-30 $3.18B $1.69B 1.88
2015-03-31 $5.13B $1.28B 4.00
2014-12-31 $5.36B $1.33B 4.05
2014-09-30 $2.63B $1.02B 2.59
2014-06-30 $2.55B $1.08B 2.37
2014-03-31 $2.30B $0.95B 2.42
2013-12-31 $2.29B $0.96B 2.38
2013-09-30 $2.37B $0.74B 3.18
2013-06-30 $2.24B $0.75B 2.99
2013-03-31 $1.70B $0.67B 2.52
2012-12-31 $1.77B $0.64B 2.79
2012-09-30 $1.90B $0.63B 3.02
2012-06-30 $1.80B $0.65B 2.75
2012-03-31 $1.79B $0.63B 2.84
2011-12-31 $1.73B $0.67B 2.60
2011-09-30 $1.30B $0.62B 2.09
2011-06-30 $1.38B $0.61B 2.27
2011-03-31 $1.26B $0.57B 2.22
2010-12-31 $1.16B $0.59B 1.98
2010-09-30 $1.02B $0.57B 1.78
2010-06-30 $1.40B $0.92B 1.52
2010-03-31 $1.15B $0.45B 2.53
2009-12-31 $1.16B $0.49B 2.39
2009-09-30 $1.10B $0.46B 2.40
2009-06-30 $1.15B $0.50B 2.30
2009-03-31 $1.04B $0.44B 2.37
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.664B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.04
Boston Scientific (BSX) United States $147.560B 37.59
Stryker (SYK) United States $144.011B 30.10
EssilorLuxottica (ESLOY) France $128.708B 0.00
Medtronic (MDT) Ireland $111.928B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.49
ResMed (RMD) United States $36.560B 27.72
Agilent Technologies (A) United States $33.258B 22.04
GE HealthCare Technologies (GEHC) United States $33.082B 15.84
Terumo (TRUMY) Japan $26.680B 34.37
Insulet (PODD) United States $21.438B 84.69
Koninklijke Philips (PHG) Netherlands $21.384B 15.43
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.71
Baxter (BAX) United States $15.713B 11.81
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.94
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.47
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.31
ICU Medical (ICUI) United States $3.250B 24.18
Envista Holdings (NVST) United States $3.127B 26.73
GN Store Nord (GNNDY) Denmark $2.263B 19.32
QuidelOrtho (QDEL) United States $1.954B 13.59
LeMaitre Vascular (LMAT) United States $1.833B 41.46
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.67
AdaptHealth (AHCO) United States $1.161B 11.81
Green Thumb Industries (GTBIF) United States $1.048B 23.71
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.80
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.55
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 5.08
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.53
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 61.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.50
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.63
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 6.12
Brainsway (BWAY) Israel $0.206B 55.30
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 15.33
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.37
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 48.64
United-Guardian (UG) United States $0.037B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00